Ankur Dhingra - 31 May 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Issuer symbol
SMMT
Transactions as of
31 May 2022
Net transactions value
$0
Form type
4
Filing time
02 Jun 2022, 17:29:35 UTC
Previous filing
28 Mar 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +600,000 600,000 31 May 2022 Common Stock 600,000 $1.33 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date).
F2 Not applicable.